BioSpyder Technologies has developed a novel product for targeted sequencing called TempO-Seq™, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, together with sequencing short fragments of each gene, enables pooling up to 6,144 samples in one sequencing run. Assay content is flexible and customizable delivering unprecedented accuracy and sensitivity.with simplified data analysis that eliminates the need for bioinformatics. TempO-Seq assays deliver an easy to use solution for customers doing expression profiling for any species.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 5928 Pascal Court,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- biospyder.com
- HQ
- Carlsbad, CA
Biospyder Technologies Questions
Biospyder Technologies's website is biospyder.com
Biospyder Technologies's LinkedIn profile is https://www.linkedin.com/company/biosypder
Biospyder Technologies has
17 employees.
View email and phone details for 17
employees at Biospyder Technologies.
Biospyder Technologies's industry is
Biotechnology Research
Biospyder Technologies's top competitors are
Genomics England,
Illumina,
Arima Genomics,
Element Biosciences,
Singular Genomics,
Computational Modeling Of Biological Systems (Sysmod) Cosi,
Chromacode, Inc.,
Guardant Health,
Celldom, Inc.,
Bioclavis Ltd.
Biospyder Technologies's categories are Biotechnology Research
Biospyder Technologies's founding year is 2011
